Literature DB >> 26996988

Obesity increases the risk of failure of noninvasive prenatal screening regardless of gestational age.

Edom Yared1, Mara J Dinsmoor2, Loraine K Endres2, Melissa J Vanden Berg2, Christin J Maier Hoell2, Brittany Lapin3, Beth A Plunkett2.   

Abstract

BACKGROUND: Noninvasive prenatal screening has become an increasingly prevalent choice for women who desire aneuploidy screening. Although the test characteristics are impressive, some women are at increased risk for noninvasive prenatal screen failure. The risk of test failure increases with maternal weight; thus, obese women may be at elevated risk for failure. This risk of failure may be mitigated by the addition of a paternal cheek swab and screening at a later gestational age.
OBJECTIVE: The purpose of this study was to evaluate the association among obesity, gestational age, and paternal cheek swab in the prevention of screening failure. STUDY
DESIGN: A retrospective cohort study was performed for women who were ≥35 years old at delivery who underwent screening at NorthShore University HealthSystem, Evanston, IL. Maternal weight, body mass index, gestational age, and a paternal cheek swab were evaluated in univariate and multivariable logistic regression analyses to assess the association with failed screening.
RESULTS: Five hundred sixty-five women met inclusion criteria for our study. The mean body mass index was 25.9 ± 5.1 kg/m(2); 111 women (20%) were obese (body mass index, ≥30 kg/m(2)). Forty-four women (7.8%) had a failed screen. Obese women had a failure rate of 24.3% compared with 3.8% in nonobese women (P < .01). Gestational age was not associated with failure rate (mean ± standard deviation, 13 ± 3 weeks for both screen failure and nonfailure; P = .76). The addition of a paternal cheek swab reduced the failure rate from 10.2% in women with no swab to 3.8% in women with a swab (P < .01). In multivariable analysis, obesity and lack of a paternal cheek swab were independent predictors of screen failure (odds ratio, 9.75; 95% confidence interval, 4.85-19.61; P < .01; and odds ratio, 3.61; 95% confidence interval, 1.56-8.33; P < .01, respectively).
CONCLUSION: The addition of a paternal cheek swab significantly improved noninvasive prenatal screen success rates in obese women. However, delaying testing to a later gestational age did not.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aneuploidy; cell-free DNA; noninvasive prenatal screening; obesity; paternal cheek swab

Mesh:

Substances:

Year:  2016        PMID: 26996988     DOI: 10.1016/j.ajog.2016.03.018

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  The Effect of Maternal Obesity on Placental Cell-Free DNA Release in a Mouse Model.

Authors:  Mohak Mhatre; Sharareh Adeli; Errol Norwitz; Sabrina Craigo; Mark Phillippe; Andrea Edlow
Journal:  Reprod Sci       Date:  2018-11-19       Impact factor: 3.060

2.  Enrichment of fetal and maternal long cell-free DNA fragments from maternal plasma following DNA repair.

Authors:  Joaquim S L Vong; Peiyong Jiang; Suk-Hang Cheng; Wing-Shan Lee; Jason C H Tsang; Tak-Yeung Leung; K C Allen Chan; Rossa W K Chiu; Y M Dennis Lo
Journal:  Prenat Diagn       Date:  2019-01-10       Impact factor: 3.050

3.  Noninvasive prenatal screening for patients with high body mass index: Evaluating the impact of a customized whole genome sequencing workflow on sensitivity and residual risk.

Authors:  Dale Muzzey; James D Goldberg; Carrie Haverty
Journal:  Prenat Diagn       Date:  2019-12-20       Impact factor: 3.050

4.  Not all low fetal fraction cell-free DNA screening failures are at increased risk for aneuploidy.

Authors:  Samantha Caldwell; Eyad Almasri; Lindsey Schmidt; Chen Xu; Brittany Dyr; Jenna Wardrop; Philip Cacheris
Journal:  Prenat Diagn       Date:  2021-03-08       Impact factor: 3.050

5.  Cell-based non-invasive prenatal testing for monogenic disorders: confirmation of unaffected fetuses following preimplantation genetic testing.

Authors:  Christian Liebst Frisk Toft; Hans Jakob Ingerslev; Ulrik Schiøler Kesmodel; Lotte Hatt; Ripudaman Singh; Katarina Ravn; Bolette Hestbek Nicolaisen; Inga Baasch Christensen; Mathias Kølvraa; Line Dahl Jeppesen; Palle Schelde; Ida Vogel; Niels Uldbjerg; Richard Farlie; Steffen Sommer; Marianne Louise Vang Østergård; Ann Nygaard Jensen; Helle Mogensen; Kristín Rós Kjartansdóttir; Birte Degn; Henrik Okkels; Anja Ernst; Inge Søkilde Pedersen
Journal:  J Assist Reprod Genet       Date:  2021-03-07       Impact factor: 3.412

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.